|
1
|
Vestbo J, Hurd SS, Agusti AG, Jones PW,
Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Mar tinez FJ,
Nishimura M, et al: Global strategy for the diagnosis, management
and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.
View Article : Google Scholar
|
|
2
|
Barnes PJ: Chronic obstructive pulmonary
disease. N Engl J Med. 343:269–280. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pellegrino R and Brusasco V: On the causes
of lung hyperinflation during bronchoconstriction. Eur Respir J.
10:468–475. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Baldi S, Miniati M, Bellina CR, Battolla
L, Catapano G, Begliomini E, Giustini D and Giuntini C:
Relationship between extent of pulmonary emphysema by
high-resolution computed tomography and lung elastic recoil in
patients with chronic obstructive pulmonary disease. Am J Respir
Crit Care Med. 164:585–589. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rutgers SR, Timens W, Kaufmann HF, van der
Mark TW, Koëter GH and Postma DS: Comparison of induced sputum with
bronchial wash, bronchoalveolar lavage and bronchial biopsies in
COPD. Eur Respir J. 15:109–115. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhowmik A, Seemungal TA, Sapsford RJ,
Devalia JL and Wedzicha JA: Comparison of spontaneous and induced
sputum for investigation of airway inflammation in chronic
obstructive pulmonary disease. Thorax. 53:953–956. 1998. View Article : Google Scholar
|
|
7
|
Saetta M, Turato G, Maestrelli P, Mapp CE
and Fabbri LM: Cellular and structural bases of chronic obstructive
pulmonary disease. Am J Respir Crit Care Med. 163:1304–1309. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wielders PL and Dekhuijzen PN: Disease
monitoring in chronic obstructive pulmonary disease: Is there a
role for biomarkers? Eur Respir J. 10:2443–2445. 1997. View Article : Google Scholar
|
|
9
|
Hunt J: Exhaled breath condensate: An
evolving tool for noninvasive evaluation of lung disease. J Allergy
Clin Immunol. 110:28–34. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carter SR, Davis CS and Kovacs EJ: Exhaled
breath condensate collection in the mechanically ventilated
patient. Respir Med. 106:601–613. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anzueto A, Jubran A, Ohar JA, Piquette CA,
Rennard SI, Colice G, Pattishall EN, Barrett J, Engle M, Perret KA
and Rubin BK: Effects of aerosolized surfactant in patients with
stable chronic bronchitis: A prospective randomized controlled
trial. JAMA. 278:1426–1431. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bernhard W, Haslam PL and Floros J: From
birds to humans: New concepts on airways relative to alveolar
surfactant. Am J Respir Cell Mol Biol. 30:6–11. 2004. View Article : Google Scholar
|
|
13
|
Milic-Emili J: Does mechanical injury of
the peripheral airways play a role in the genesis of COPD in
smokers? COPD. 1:85–92. 2004. View Article : Google Scholar
|
|
14
|
Sin DD, Pahlavan PS and Man SF: Surfactant
protein D: A lung specific biomarker in COPD? Ther Adv Respir Dis.
2:65–74. 2008. View Article : Google Scholar
|
|
15
|
Guo X, Lin HM, Lin Z, Montaño M, Sansores
R, Wang G, DiAngelo S, Pardo A, Selman M and Floros J:
Polymorphisms of surfactant protein gene A, B, D, and of
SP-B-linked micro-satellite markers in COPD of a Mexican
population. Chest. 117:249S–250S. 2000. View Article : Google Scholar
|
|
16
|
Otto-Verberne CJ, Ten Have-Opbroek AA,
Franken C, Hermans J and Dijkman JH: Protective effect of pulmonary
surfactant on elastase-induced emphysema in mice. Eur Respir J.
5:1223–1230. 1992.PubMed/NCBI
|
|
17
|
Kishore U, Greenhough TJ, Waters P, Shrive
AK, Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T and Chakraborty
T: Surfactant proteins SP-A and SP-D: Structure, function and
receptors. Mol Immunol. 43:1293–1315. 2006. View Article : Google Scholar
|
|
18
|
Pastva AM, Wright JR and Williams KL:
Immunomodulatory roles of surfactant proteins A and D: Implications
in lung disease. Proc Am Thorac Soc. 4:252–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Honda Y, Takahashi H, Kuroki Y, Akino T
and Abe S: Decreased contents of surfactant proteins A and D in BAL
fluids of healthy smokers. Chest. 109:1006–1009. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Betsuyaku T, Kuroki Y, Nagai K, Nasuhara Y
and Nishimura M: Effects of ageing and smoking on SP-A and SP-D
levels in bronchoalveolar lavage fluid. Eur Respir J. 24:964–970.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vlachaki EM, Koutsopoulos AV, Tzanakis N,
Neofytou E, Siganaki M, Drositis I, Moniakis A, Schiza S, Siafakas
NM and Tzortzaki EG: Altered surfactant protein-A expression in
type II pneumocytes in COPD. Chest. 137:37–45. 2010. View Article : Google Scholar
|
|
22
|
Rahman I and Biswas SK: Non-invasive
biomarkers of oxidative stress: Reproducibility and methodological
issues. Redox Rep. 9:125–143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Celli BR and MacNee W; ATS/ERS Task Force:
Standards for the diagnosis and treatment of patients with COPD: A
summary of the ATS/ERS position paper. Eur Respir J. 23:932–946.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mutti A, Corradi M, Goldoni M, Vettori MV,
Bernard A and Apostoli P: Exhaled metallic elements and serum
pneumoproteins in asymptomatic smokers and patients with COPD or
asthma. Chest. 129:1288–1297. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kharitonov SA and Barnes PJ: Exhaled
markers of pulmonary disease. Am J Respir Crit Care Med.
163:1693–1722. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jöbsis Q, Raatgeep HC, Schellekens SL,
Kroesbergen A, Hop WC and de Jongste JC: Hydrogen peroxide and
nitric oxide in exhaled air of children with cystic fibrosis during
antibiotic treatment. Eur Respir J. 16:95–100. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo X, Lin HM, Lin Z, Montaño M, Sansores
R, Wang G, DiAngelo S, Pardo A, Selman M and Floros J: Surfactant
protein gene A, B and D marker alleles in chronic obstructive
pulmonary disease of a Mexican population. Eur Respir J.
18:482–490. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ohlmeier S, Vuolanto M, Toljamo T, Vuopala
K, Salmenkivi K, Myllärniemi M and Kinnula VL: Proteomics of human
lung tissue identifies surfactant protein A as a marker of chronic
obstructive pulmonary disease. J Proteome Res. 7:5125–5132. 2008.
View Article : Google Scholar
|
|
29
|
Wirtz HR and Schmidt M: Acute influence of
cigarette smoke on secretion of pulmonary surfactant in rat
alveolar type II cells in culture. Eur Respir J. 9:24–32. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Subramaniam S, Whitsett JA, Hull W and
Gairola CG: Alteration of pulmonary surfactant proteins in rats
chronically exposed to cigarette smoke. Toxicol Appl Pharmacol.
140:274–280. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Garcia O, Hiatt MJ, Lundin A, Lee J, Reddy
R, Navarro S, Kikuchi A and Driscoll B: Targeted type 2 alveolar
cell depletion provides a dynamic functional model for lung injury
repair. Am J Respir Cell Mol Biol. Jul 23–2015.Epub ahead of print.
View Article : Google Scholar
|
